Michael Ulz
Stock Analyst at Morgan Stanley
(3.19)
# 2,538
Out of 4,639 analysts
583
Total ratings
44.9%
Success rate
2.3%
Average return
Main Sectors:
Stocks Rated by Michael Ulz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RCKT Rocket Pharmaceuticals | Rated: Hold | $5 | $3.50 | +42.86% | 19 | Aug 12, 2026 | |
| KYTX Kyverna Therapeutics | Maintained: Buy | $33 | $8.02 | +311.47% | 24 | Aug 12, 2026 | |
| AARD Aardvark Therapeutics | Rated: Sell | $3 | $7.19 | -58.28% | 9 | Aug 12, 2026 | |
| SLN Silence Therapeutics | Rated: Buy | $25 → $32 | $14.72 | +117.39% | 34 | Aug 11, 2026 | |
| GUTS Fractyl Health | Rated: Hold | $2 | $0.7018 | +184.98% | 18 | Aug 11, 2026 | |
| ZNTL Zentalis Pharmaceuticals | Rated: Hold | $4 → $5 | $4.11 | +21.65% | 13 | Aug 7, 2026 | |
| BIOA BioAge Labs | Maintained: Hold | $23 → $20 | $10.67 | +87.44% | 16 | Aug 7, 2026 | |
| ARWR Arrowhead Pharmaceuticals | Rated: Buy | $120 | $89.24 | +34.47% | 27 | Aug 6, 2026 | |
| SRPT Sarepta Therapeutics | Rated: Hold | $25 | $18.22 | +37.21% | 31 | Aug 6, 2026 | |
| MIRM Mirum Pharmaceuticals | Rated: Buy | $150 → $137 | $98.23 | +39.47% | 25 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $27 → $25 | $8.93 | +179.96% | 24 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $136 → $150 | $112.85 | +32.93% | 21 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $400 → $300 | $221.20 | +35.62% | 47 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 → $45 | $26.71 | +68.48% | 25 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $110 | $55.42 | +98.48% | 39 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 | $33.80 | +181.07% | 25 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $13 | $2.79 | +365.95% | 21 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2 | $0.7513 | +166.21% | 15 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $0.39 → $0.36 | $0.002 | +17,900.00% | 13 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $9.18 | n/a | 8 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 | $2.74 | n/a | 13 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $20 → $5 | $11.45 | n/a | 2 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.5 | $3.97 | n/a | 7 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.10 | n/a | 18 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.3573 | n/a | 3 | Dec 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $40 | $28.73 | n/a | 12 | Aug 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $60 → $23 | $6.49 | n/a | 2 | May 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $3 | $6.68 | n/a | 1 | Jan 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $7 → $3 | $31.87 | n/a | 2 | Jan 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $69.55 | n/a | 15 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.21 | n/a | 12 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $26.96 | n/a | 13 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $35.80 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $36.84 | n/a | 2 | Mar 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $340 | $864.74 | n/a | 6 | Mar 4, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $69 → $60 | $7.52 | n/a | 2 | Mar 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $25.96 | n/a | 3 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $37 | $20.29 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $0.68 | n/a | 1 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $45 | $13.73 | n/a | 1 | Aug 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $15 → $8 | $0.0001 | n/a | 4 | Jul 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $40 | $3.91 | n/a | 5 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | n/a | $5.90 | n/a | 1 | Oct 3, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $28 | $135.77 | n/a | 1 | May 18, 2010 |
Rocket Pharmaceuticals
Aug 12, 2026
Rated: Hold
Price Target: $5
Current: $3.50
Upside: +42.86%
Kyverna Therapeutics
Aug 12, 2026
Maintained: Buy
Price Target: $33
Current: $8.02
Upside: +311.47%
Aardvark Therapeutics
Aug 12, 2026
Rated: Sell
Price Target: $3
Current: $7.19
Upside: -58.28%
Silence Therapeutics
Aug 11, 2026
Rated: Buy
Price Target: $25 → $32
Current: $14.72
Upside: +117.39%
Fractyl Health
Aug 11, 2026
Rated: Hold
Price Target: $2
Current: $0.7018
Upside: +184.98%
Zentalis Pharmaceuticals
Aug 7, 2026
Rated: Hold
Price Target: $4 → $5
Current: $4.11
Upside: +21.65%
BioAge Labs
Aug 7, 2026
Maintained: Hold
Price Target: $23 → $20
Current: $10.67
Upside: +87.44%
Arrowhead Pharmaceuticals
Aug 6, 2026
Rated: Buy
Price Target: $120
Current: $89.24
Upside: +34.47%
Sarepta Therapeutics
Aug 6, 2026
Rated: Hold
Price Target: $25
Current: $18.22
Upside: +37.21%
Mirum Pharmaceuticals
Aug 6, 2026
Rated: Buy
Price Target: $150 → $137
Current: $98.23
Upside: +39.47%
Aug 6, 2026
Rated: Buy
Price Target: $27 → $25
Current: $8.93
Upside: +179.96%
Aug 5, 2026
Rated: Buy
Price Target: $136 → $150
Current: $112.85
Upside: +32.93%
Jul 31, 2026
Maintained: Hold
Price Target: $400 → $300
Current: $221.20
Upside: +35.62%
Jul 31, 2026
Maintained: Buy
Price Target: $47 → $45
Current: $26.71
Upside: +68.48%
Jul 30, 2026
Maintained: Buy
Price Target: $110
Current: $55.42
Upside: +98.48%
Jul 30, 2026
Maintained: Buy
Price Target: $95
Current: $33.80
Upside: +181.07%
Jun 3, 2026
Maintained: Buy
Price Target: $13
Current: $2.79
Upside: +365.95%
Jun 3, 2026
Reiterated: Buy
Price Target: $2
Current: $0.7513
Upside: +166.21%
Jan 8, 2026
Downgraded: Sell
Price Target: $0.39 → $0.36
Current: $0.002
Upside: +17,900.00%
Mar 11, 2025
Maintained: Buy
Price Target: $5
Current: $9.18
Upside: n/a
Mar 6, 2025
Maintained: Hold
Price Target: $5
Current: $2.74
Upside: n/a
Feb 11, 2025
Downgraded: Hold
Price Target: $20 → $5
Current: $11.45
Upside: n/a
Aug 13, 2024
Maintained: Sell
Price Target: $0.5
Current: $3.97
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $2.10
Upside: n/a
Dec 15, 2023
Rated: Hold
Price Target: n/a
Current: $0.3573
Upside: n/a
Aug 22, 2023
Maintained: Hold
Price Target: $40
Current: $28.73
Upside: n/a
May 22, 2023
Rated: Buy
Price Target: $60 → $23
Current: $6.49
Upside: n/a
Jan 27, 2023
Downgraded: Hold
Price Target: $3
Current: $6.68
Upside: n/a
Jan 5, 2022
Maintained: Hold
Price Target: $7 → $3
Current: $31.87
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $69.55
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $1.21
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $26.96
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $35.80
Upside: n/a
Mar 12, 2021
Rated: Hold
Price Target: n/a
Current: $36.84
Upside: n/a
Mar 4, 2021
Maintained: Buy
Price Target: $340
Current: $864.74
Upside: n/a
Mar 1, 2021
Maintained: Hold
Price Target: $69 → $60
Current: $7.52
Upside: n/a
Feb 16, 2021
Reiterated: Buy
Price Target: n/a
Current: $25.96
Upside: n/a
Jan 29, 2021
Maintained: Buy
Price Target: $37
Current: $20.29
Upside: n/a
Jan 29, 2021
Maintained: Buy
Price Target: $5
Current: $0.68
Upside: n/a
Aug 12, 2020
Initiated Coverage: Buy
Price Target: $45
Current: $13.73
Upside: n/a
Jul 30, 2020
Maintained: Buy
Price Target: $15 → $8
Current: $0.0001
Upside: n/a
Mar 28, 2019
Maintained: Hold
Price Target: $3 → $40
Current: $3.91
Upside: n/a
Oct 3, 2017
Rated: Buy
Price Target: n/a
Current: $5.90
Upside: n/a
May 18, 2010
Maintained: Buy
Price Target: $28
Current: $135.77
Upside: n/a